Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 168,609,792
  • Shares Outstanding, K 1,741,657
  • Annual Sales, $ 44,328 M
  • Annual Income, $ 6,524 M
  • EBIT $ 9,735 M
  • EBITDA $ 12,851 M
  • 60-Month Beta 0.79
  • Price/Sales 3.75
  • Price/Cash Flow 13.66
  • Price/Book 3.15

Options Overview Details

View History
  • Implied Volatility 24.09% (-1.42%)
  • Historical Volatility 25.81%
  • IV Percentile 66%
  • IV Rank 41.14%
  • IV High 34.27% on 03/27/26
  • IV Low 16.97% on 08/12/25
  • Expected Move (DTE 6) 2.17 (2.24%)
  • Put/Call Vol Ratio 1.48
  • Today's Volume 23,057
  • Volume Avg (30-Day) 13,749
  • Put/Call OI Ratio 1.00
  • Today's Open Interest 197,671
  • Open Int (30-Day) 153,949
  • Expected Range 94.64 to 98.98

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.28
  • Number of Estimates 4
  • High Estimate $1.28
  • Low Estimate $1.28
  • Prior Year $1.26
  • Growth Rate Est. (year over year) +1.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
93.92 +3.08%
on 04/16/26
109.94 -11.95%
on 03/18/26
-13.90 (-12.56%)
since 03/17/26
3-Month
93.92 +3.08%
on 04/16/26
122.49 -20.96%
on 01/21/26
-24.95 (-20.49%)
since 01/16/26
52-Week
93.92 +3.08%
on 04/16/26
139.06 -30.38%
on 06/24/25
-34.17 (-26.09%)
since 04/17/25

Most Recent Stories

More News
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

ABBOTT PARK, Ill. , April 17, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will present new data at the American Association for Cancer Research (AACR) Annual Meeting 2026 demonstrating continued advancements...

ABT : 96.81 (+1.40%)
Abbott Stock Crash: Rebound Could Be Coming Fast

Abbott Laboratories' stock price sell-off is overextended in mid-April, creating an opportunity that income investors will not want to miss.

ABT : 96.81 (+1.40%)
Abbott Labs’ Financial Results Narrowly Beat Forecasts

Abbott Laboratories (ABT) has reported first-quarter financial results that narrowly beat Wall Street’s ...

ABT : 96.81 (+1.40%)
Stocks Settle Higher on Tech Earnings and Ceasefire Optimism

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.26%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.49%. June E-mini...

ALK : 45.40 (+10.33%)
ADI : 371.45 (+4.99%)
GLW : 164.38 (-1.02%)
AMD : 278.39 (+0.05%)
SPY : 710.14 (+1.21%)
ADSK : 242.02 (-0.47%)
ORCL : 175.06 (-1.84%)
DOW : 35.60 (-10.82%)
DKS : 224.36 (+2.98%)
VOYG : 31.31 (-3.78%)
QQQ : 648.85 (+1.31%)
FTNT : 81.84 (-0.68%)
Stocks Edge Higher as Chipmakers Rebound

The S&P 500 Index ($SPX ) (SPY ) today is up +0.21%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.43%. June E-mini S&P futures (ESM26...

ALK : 45.40 (+10.33%)
FLUT : 110.08 (+0.94%)
ADI : 371.45 (+4.99%)
HIMS : 28.82 (+6.78%)
PPG : 114.85 (+2.40%)
FN : 689.89 (+2.56%)
TXN : 229.82 (+3.01%)
$IUXX : 26,672.43 (+1.29%)
ZNM26 : 111-230s (+0.45%)
ABT : 96.81 (+1.40%)
GLW : 164.38 (-1.02%)
ESM26 : 7,161.50s (+1.19%)
Stocks Pressured by Weakness in Chipmakers

The S&P 500 Index ($SPX ) (SPY ) today is down -0.15%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.21%. June E-mini S&P futures...

AMAT : 396.94 (+1.81%)
INTU : 393.25 (+1.59%)
FLUT : 110.08 (+0.94%)
HIMS : 28.82 (+6.78%)
PPG : 114.85 (+2.40%)
FN : 689.89 (+2.56%)
$IUXX : 26,672.43 (+1.29%)
ASML : 1,459.80 (+3.47%)
ZNM26 : 111-230s (+0.45%)
ABT : 96.81 (+1.40%)
GLW : 164.38 (-1.02%)
ESM26 : 7,161.50s (+1.19%)
Abbott Laboratories’s (NYSE:ABT) Q1 CY2026 Sales Top Estimates

Abbott Laboratories’s (NYSE:ABT) Q1 CY2026 Sales Top Estimates

ABT : 96.81 (+1.40%)
Abbott: Q1 Earnings Snapshot

Abbott: Q1 Earnings Snapshot

ABT : 96.81 (+1.40%)
Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences

ABBOTT PARK, Ill. , April 16, 2026 /PRNewswire/ -- Abbott today (NYSE: ABT) announced financial results for the first quarter ended March 31, 2026.

ABT : 96.81 (+1.40%)
Nasdaq Futures Climb as TSMC Boosts Tech Optimism

June Nasdaq 100 E-Mini futures (NQM26) are trending up +0.32% this morning, setting a new record high as an upbeat forecast from Taiwan Semiconductor Manufacturing Co. boosted sentiment.

KLAC : 1,791.44 (+3.26%)
NFLX : 97.31 (-9.72%)
PYPL : 50.81 (+2.01%)
AMAT : 396.94 (+1.81%)
GTLB : 21.42 (-1.88%)
SNDK : 920.99 (+0.17%)
JBHT : 245.08 (+2.84%)
DDOG : 126.61 (+2.54%)
PLD : 145.10 (+2.06%)
OKTA : 72.25 (+0.33%)
BARN.Z.IX : 1,075.500 (+0.51%)
TSLA : 400.62 (+3.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 30%. The market has bounced from oversold territory. Beware of a potential mean reversion.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 99.95
2nd Resistance Point 98.54
1st Resistance Point 97.68
Last Price 96.81
1st Support Level 95.41
2nd Support Level 94.00
3rd Support Level 93.14

See More

52-Week High 139.06
Fibonacci 61.8% 121.82
Fibonacci 50% 116.49
Fibonacci 38.2% 111.16
Last Price 96.81
52-Week Low 93.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.